NASDAQ: ELDN
Eledon Pharmaceuticals Inc Stock Ownership - Who owns Eledon Pharmaceuticals?

Insider buying vs selling

Have Eledon Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ELDN insiders and whales buy or sell their stock.

ELDN Shareholders

What type of owners hold Eledon Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Seth Loring Harrison13.57%8,124,773$23.48MInsider
Bvf Inc10.51%6,293,282$18.19MInstitution
Erez Chimovits9.55%5,720,424$16.53MInsider
Novartis Bioventures Ltd7.50%4,493,458$12.99MInsider
Apple Tree Partners II LP7.04%4,218,641$12.19MInsider
Apple Tree Partners II Annex LP5.96%3,568,438$10.31MInsider
Ra Capital Management LP5.96%3,566,338$10.31MInstitution
Vanguard Group Inc4.83%2,894,639$8.37MInstitution
Sphera Funds Management Ltd4.26%2,551,619$7.37MInstitution
First Light Asset Management LLC3.89%2,328,768$6.73MInstitution

1 of 3

ELDN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ELDN55.81%44.19%
CTMX57.95%26.79%Net SellingNet Selling
PRQR41.24%0.00%
FENC4.45%95.55%Net SellingNet Selling
SGMO26.38%13.81%Net SellingNet Selling

Eledon Pharmaceuticals Stock Ownership FAQ

Who owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals (NASDAQ: ELDN) is owned by 64.28% institutional shareholders, 50.89% Eledon Pharmaceuticals insiders, and 0.00% retail investors. Seth Loring Harrison is the largest individual Eledon Pharmaceuticals shareholder, owning 8.12M shares representing 13.57% of the company. Seth Loring Harrison's Eledon Pharmaceuticals shares are currently valued at $23.32M.

If you're new to stock investing, here's how to buy Eledon Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.